CHX Technologies is a research-intensive pharmaceutical company with a unique focus on preventive oral healthcare. CHX has an approved drug, Prevora, which manages the primary cause of poor oral health in adults — a condition called oral dysbiosis. Prevora is a high-strength, sustained-release, broad spectrum antiseptic applied by a hygienist or nurse to the teeth of high risk adults experiencing cavities and/or oral inflammation. Prevora is painless, very safe, very effective and its application is quick. Prevora patients enjoy years of improved oral health and commonly report they feel better too. CHX has approval for Prevora in Canada, Ireland, the UK and the EU. CHX is conducting studies to integrate Prevora in to medical practices, hospitals, seniors’ centres and pharmacies so as to expand access to oral healthcare.